[1] Belsky DW, Caspi A, Houts R, et al. Quantification of biological aging in young adults. Proc Natl Acad Sci USA, 2015; 112, E4104−10. doi:  10.1073/pnas.1501574112
[2] Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 2001; 56, M146−56. doi:  10.1093/gerona/56.3.M146
[3] Damluji AA, Chung SE, Xue QL, et al. Frailty and cardiovascular outcomes in the national health and aging trends study. Eur Heart J, 2021; 42, 3856−65. doi:  10.1093/eurheartj/ehab468
[4] Wu YJ, Xiong T, Tan X, et al. Frailty and risk of microvascular complications in patients with type 2 diabetes: a population-based cohort study. BMC Med, 2022; 20, 473. doi:  10.1186/s12916-022-02675-9
[5] Cao XQ, Li XQ, Zhang JY, et al. Associations between frailty and the increased risk of adverse outcomes among 38, 950 UK Biobank participants with prediabetes: prospective cohort study. JMIR Public Health Surveill, 2023; 9, e45502. doi:  10.2196/45502
[6] Zheng ZK, Lv YL, Rong S, et al. Physical frailty, genetic predisposition, and incident Parkinson disease. JAMA Neurol, 2023; 80, 455−61. doi:  10.1001/jamaneurol.2023.0183
[7] Wu SH, Liu Z, Ho SC. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. Eur J Epidemiol, 2010; 25, 375−84. doi:  10.1007/s10654-010-9459-z
[8] Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol, 2010; 56, 1113−32. doi:  10.1016/j.jacc.2010.05.034
[9] Brauer M, Roth GA, Aravkin AY, et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021. Lancet, 2024; 403, 2162−203. doi:  10.1016/S0140-6736(24)00933-4
[10] O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev, 2015; 16, 1−12.
[11] Dao HHH, Burns MJ, Kha R, et al. The relationship between metabolic syndrome and frailty in older people: a systematic review and meta-analysis. Geriatrics, 2022; 7, 76. doi:  10.3390/geriatrics7040076
[12] Mishra M, Wu J, Kane AE, et al. The intersection of frailty and metabolism. Cell Metab, 2024; 36, 893−911. doi:  10.1016/j.cmet.2024.03.012
[13] Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med, 2015; 12, e1001779. doi:  10.1371/journal.pmed.1001779
[14] Hanlon P, Nicholl BI, Jani BD, et al. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health, 2018; 3, e323−32. doi:  10.1016/S2468-2667(18)30091-4
[15] Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009; 120, 1640−5. doi:  10.1161/CIRCULATIONAHA.109.192644
[16] Watson NF, Badr MS, Belenky G, et al. Joint consensus statement of the American academy of sleep medicine and sleep research society on the recommended amount of sleep for a healthy adult: methodology and discussion. Sleep, 2015; 38, 1161−83. doi:  10.5665/sleep.4886
[17] Townsend P, Phillimore P, Beattie A. Health and deprivation: inequality and the North. Routledge. 1988.
[18] Said MA, Verweij N, van der Harst P. Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK Biobank study. JAMA Cardiol, 2018; 3, 693−702. doi:  10.1001/jamacardio.2018.1717
[19] He D, Wang ZP, Li J, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J, 2024; 45, 1058−68. doi:  10.1093/eurheartj/ehad885
[20] Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology, 1992; 3, 452−6. doi:  10.1097/00001648-199209000-00012
[21] Chen LK, Li XB, Lv YL, et al. Physical frailty, adherence to ideal cardiovascular health and risk of cardiovascular disease: a prospective cohort study. Age Ageing, 2023; 52, afac311. doi:  10.1093/ageing/afac311
[22] Fan JN, Yu CQ, Guo Y, et al. Frailty index and all-cause and cause-specific mortality in Chinese adults: a prospective cohort study. Lancet Public Health, 2020; 5, e650−60. doi:  10.1016/S2468-2667(20)30113-4
[23] Peng Y, Zhong GC, Zhou XL, et al. Frailty and risks of all-cause and cause-specific death in community-dwelling adults: a systematic review and meta-analysis. BMC Geriatr, 2022; 22, 725. doi:  10.1186/s12877-022-03404-w
[24] Dumurgier J, Elbaz A, Ducimetière P, et al. Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. BMJ, 2009; 339, b4460. doi:  10.1136/bmj.b4460
[25] Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet, 2012; 380, 219−29. doi:  10.1016/S0140-6736(12)61031-9
[26] Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol, 2012; 2, 1143−211. doi:  10.1002/j.2040-4603.2012.tb00425.x
[27] Jiang RT, Westwater ML, Noble S, et al. Associations between grip strength, brain structure, and mental health in > 40, 000 participants from the UK Biobank. BMC Med, 2022; 20, 286. doi:  10.1186/s12916-022-02490-2
[28] Farmer RE, Mathur R, Schmidt AF, et al. Associations between measures of sarcopenic obesity and risk of cardiovascular disease and mortality: a cohort study and Mendelian randomization analysis using the UK Biobank. J Am Heart Assoc, 2019; 8, e011638. doi:  10.1161/JAHA.118.011638
[29] Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the prospective urban rural epidemiology (PURE) study. Lancet, 2015; 386, 266−73. doi:  10.1016/S0140-6736(14)62000-6
[30] Kane AE, Gregson E, Theou O, et al. The association between frailty, the metabolic syndrome, and mortality over the lifespan. GeroScience, 2017; 39, 221−9. doi:  10.1007/s11357-017-9967-9
[31] Caldo-Silva A, Furtado GE, Chupel MU, et al. Effect of training-detraining phases of multicomponent exercises and BCAA supplementation on inflammatory markers and albumin levels in frail older persons. Nutrients, 2021; 13, 1106. doi:  10.3390/nu13041106
[32] Biesek S, Vojciechowski AS, Filho JM, et al. Effects of exergames and protein supplementation on body composition and musculoskeletal function of prefrail community-dwelling older women: a randomized, controlled clinical trial. Int J Environ Res Public Health, 2021; 18, 9324. doi:  10.3390/ijerph18179324
[33] Ng TP, Feng L, Nyunt MSZ, et al. Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: a randomized controlled trial. Am J Med, 2015; 128, 1225-36. e1.
[34] Puts MTE, Toubasi S, Andrew MK, et al. Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a scoping review of the literature and international policies. Age Ageing, 2017; 46, 383−92.
[35] Nishikawa H, Asai A, Fukunishi S, et al. Metabolic syndrome and sarcopenia. Nutrients, 2021; 13, 3519. doi:  10.3390/nu13103519
[36] Dzięgielewska-Gęsiak S, Muc-Wierzgoń M. Inflammation and oxidative stress in frailty and metabolic syndromes-two sides of the same coin. Metabolites, 2023; 13, 475. doi:  10.3390/metabo13040475
[37] El Assar M, Rodríguez-Sánchez I, Álvarez-Bustos A, et al. Biomarkers of frailty. Mol Aspects Med, 2024; 97, 101271. doi:  10.1016/j.mam.2024.101271
[38] VanderWeele TJ. Principles of confounder selection. Eur J Epidemiol, 2019; 34, 211−9. doi:  10.1007/s10654-019-00494-6
[39] Yamada Y, Kato K, Oguri M, et al. Identification of 13 novel susceptibility loci for early-onset myocardial infarction, hypertension, or chronic kidney disease. Int J Mol Med, 2018; 42, 2415−36.
[40] Sattar N, Rawshani A, Franzén S, et al. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks. Circulation, 2019; 139, 2228−37. doi:  10.1161/CIRCULATIONAHA.118.037885
[41] Wang C, Yuan Y, Zheng MY, et al. Association of age of onset of hypertension with cardiovascular diseases and mortality. J Am Coll Cardiol, 2020; 75, 2921−30.